PLUS1
1.63
-0.08 (-4.68%)
-0.08 (-4.68%)
Upgrade to Real-Time
Afterhours
| Volume | 181,730 |
|
|||||
| News | - | ||||||
| Day High | 1.69 | Low High |
|||||
| Day Low | 1.61 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.08 | -4.68% | 1.63 | 17:20:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.68 | 1.61 | 1.69 | 1.63 | 1.71 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 549 | 181,730 | $ 1.65 | $ 300,157 | - | 1.57 - 4.36 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:12:33 | 43 | $ 1.63 | USD |
Period:
Draw Mode:
Phio Pharmaceuticals Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.06M | 13.53M | 13.50M | $ - | $ - | -2.48 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 10.50% |
Phio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.66 | 1.81 | 1.61 | 1.69 | 225,250 | -0.03 | -1.81% |
| 1 Month | 2.15 | 2.19 | 1.59 | 1.80 | 220,891 | -0.52 | -24.19% |
| 3 Months | 1.82 | 2.40 | 1.57 | 2.03 | 465,975 | -0.19 | -10.44% |
| 6 Months | 2.38 | 2.85 | 1.57 | 2.25 | 650,116 | -0.75 | -31.51% |
| 1 Year | 2.17 | 4.36 | 1.57 | 2.73 | 791,355 | -0.54 | -24.88% |
| 3 Years | 0.39 | 10.85 | 0.097 | 1.83 | 712,527 | 1.24 | 317.95% |
| 5 Years | 0.39 | 10.85 | 0.097 | 1.83 | 712,527 | 1.24 | 317.95% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |
